Current treatments only relieve the symptoms of the disease with physiotherapy and painkillers although some patients are being given an antibody treatment which costs £10,000 a year. Lead researcher Professor Paul Wordsworth said: “We knew there was a strong genetic component to this disease, and we now have the foundation we need for future research to pin down the genetic causes of this condition. ... Click Here to Read More Click Here to Read More
